From the Globe and Mail:
Agency seeks to tighten guidelines
The agency that approves the cost of prescription drugs in Canada wants to tighten its guidelines in the wake of widespread price increases pushed through by the pharmaceutical industry this year.

“I do not want to be alarmist, but I do want to raise an alarm,” Robert Elgie, chairman of the Patented Medicine Prices Review Board, told a conference of pharmaceutical executives in Toronto earlier this week.